Current Allergy and Asthma Reports

, Volume 6, Issue 6, pp 475–482 | Cite as

Eosinophilic disorders in children

Article

Abstract

Many pediatric diseases demonstrate blood or tissue eosinophilia. Included among these disorders are common atopic diatheses such as asthma as well as the rarer conditions of hypereosinophilic syndrome and eosinophilic gastrointestinal disorders. Eosinophil trafficking and activation in target organs leads to tissue damage and ongoing reparative attempts that can ultimately result in changes in organ structure and function. Recent treatment with biologic agents such as tyrosine kinase inhibitors and anti-interleukin-5 has offered new therapeutic options in certain eosinophilic disorders. Eosinophilic disorders such as eosinophilic esophagitis are increasingly being diagnosed in children, but many lessons in disease pathogenesis, diagnosis, optimal treatment, and natural history continue to be learned.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Rothenberg ME, Hogan SP: The Eosinophil. Annu Rev Immunol 2006, 24:147–174. excellent comprehensive review of eosinophil biology and functionPubMedCrossRefGoogle Scholar
  2. 2.
    Kato M, Kephart GM, Talley NJ, et al.: Eosinophil infiltration and degranulation in normal human tissue. Anat Rec 1998, 3:418–425.CrossRefGoogle Scholar
  3. 3.
    Martinez-Moczygemba M, Huston DP: Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF. J Allergy Clin Immunol 2003, 112:653–665.PubMedCrossRefGoogle Scholar
  4. 4.
    Wardlaw AJ: Molecular basis for selective eosinophil trafficking in asthma: a multistep paradigm. J Allergy Clin Immunol 1999, 104:917–926.PubMedCrossRefGoogle Scholar
  5. 5.
    Rothenberg ME: Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 2003, 113:11–28.CrossRefGoogle Scholar
  6. 6.
    Gleich GJ, Leiferman KM: The hypereosinophilic syndromes: still more heterogeneity. Curr Opin Immunol 2005, 6:679–684.CrossRefGoogle Scholar
  7. 7.
    Weller PF: Eosinophilia and eosinophil related disorders. In Middleton’s Allergy Principles and Practice. Edited byAdkinson NF, Yunginger JW, Busse WW, et al.: Philadelphia:Mosby; 2003:1105–1126.Google Scholar
  8. 8.
    Foster PF, Sankary HN, Hart M, et al.: Blood and graft eosinophilia as predictors of rejection in human liver transplantation. Transplantation 1989, 47:72–74.PubMedCrossRefGoogle Scholar
  9. 9.
    Flood-Page P, Menzies-Gow A, Phipps S, et al.: Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003, 112:1029–1036.PubMedCrossRefGoogle Scholar
  10. 10.
    de Almeida MB, Bussamra MH, Rodrigues JC: Allergic bronchopulmonary aspergillosis in paediatric cystic fibrosis patients. Paediatr Respir Rev 2006, 7:67–72.PubMedCrossRefGoogle Scholar
  11. 11.
    Hardy WR, Anderson RE: The hyperesoinophilic syndromes. Ann Intern Med 1968, 68:1220–1229.PubMedGoogle Scholar
  12. 12.
    Chusid MJ, Dale DC, West BD, et al.: The hyperesoinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine 1975, 54:1–24.PubMedCrossRefGoogle Scholar
  13. 13.
    Klion AD, Bochner BS, Gleich GJ, et al.: Approaches to the treatment of hypereosinophilic syndrome: a workshop summary report. J Allergy Clin Immunol 2006, 117:1292–1302.PubMedCrossRefGoogle Scholar
  14. 14.
    Katz HT, Haque J, Hsieh F: Pediatric hypereosinophilic syndrome (HES) differs from adult HES. J Pediatr 2005, 1146:134–136. The largest clinical series of pediatric HES.Google Scholar
  15. 15.
    Cools J, DeAngelo DJ, Gotlib J, et al.: A novel tyrosine kinase created by the fusion of the PDGFRA and FIP1L1 genes is a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003, 348:1201–1214. The first description of the fusion gene involved in adult HES.PubMedCrossRefGoogle Scholar
  16. 16.
    Yamada Y, Rothenberg ME, Lee AW, et al.: The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinohilic leukemia (CEL)-like disease. Blood 2006, 107:4071–4079.PubMedCrossRefGoogle Scholar
  17. 17.
    Rives S, Alcorta I, Toll T: Idiopathic hypereosinophilic syndrome in children: report of a 7-year-old boy with FIP1L1-PDGFRA rearrangement. J Pediatr Hematol Oncol 2005, 27:663–665.PubMedCrossRefGoogle Scholar
  18. 18.
    Wallen N, Kita H, Weiler D, et al.: Glucocorticoids inhibit cytokine mediated eosinophil survival. J Immunol 1991, 147:3490–3495.PubMedGoogle Scholar
  19. 19.
    Schandene L, Roufousse F, deLavareille A, et al.: Interferon alpha prevents spontaneous apoptosis of clonal Th2 cells associated with chronic hypereosinophilia. Blood 2000, 96:4285–4292.PubMedGoogle Scholar
  20. 20.
    Chehade M, Magid MS, Mofidi S, et al.: Allergic eosinophilic gastroenteritis with protein losing enteropathy: intestinal pathology, clinical course and long-term followup. J Pediatr Gastroenterol Nutr 2006, 42:516–521.PubMedCrossRefGoogle Scholar
  21. 21.
    Aceves SS, Newbury RO, Dohil R, et al.: Distinguishing eosinophilic esophagitis in pediatric patients: clinical, endoscopic and histologic features of an emerging disorder. J Clin Gastroenterol 2006, In press. The only currently available case-control study comparing features of pediatric EE and non-EE patients.Google Scholar
  22. 22.
    Straumann A, Simon HU: Eosionphilic esophagitis: escalating epidemiology? J Allergy Clin Immunology 2005, 115:418–419.CrossRefGoogle Scholar
  23. 23.
    Noel RJ, Putnam PE, Rothenberg ME: Eosinophilic esophagitis. N Engl J Med 2004, 351:940–941. A letter to the editor documenting the increasing incidence of pediatric EE.PubMedCrossRefGoogle Scholar
  24. 24.
    Ruchelli E, Wenner W, Voytek T, et al.: Severity of esophageal eosinophilia predicts response to conventional gastroesophageal reflux therapy. Pediatr Dev Pathol 1999, 2:15–18.PubMedCrossRefGoogle Scholar
  25. 25.
    Liacouras CA: Eosinophilic esophagitis: treatment in 2005. Curr Opin Gastroenterol 2006, 22:147–152. An excellent review of current therapies utilized in EE.PubMedCrossRefGoogle Scholar
  26. 26.
    Mueller S, Aigner T, Neureiter D, et al.: Eosinophil infiltration and degranulation in esophageal mucosa from adult patients with eosinophilic esophagitis. A retrospective comparative pathologic biopsy study. J Clin Pathol 2006, In press.Google Scholar
  27. 27.
    Straumann A, Kristl J, Conus S, et al.: Cytokine expression in healthy and inflamed mucosa: probling the role of eosinophils in the digestive tract. Inflamm Bowel Dis 2005, 11:720–726.PubMedCrossRefGoogle Scholar
  28. 28.
    Noel RJ, Putnam PE, Collins MH, et al.: Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol 2004, 2:568–75.PubMedCrossRefGoogle Scholar
  29. 29.
    Steiner S, Kernek KM, Fitzgerald JF: Severity of basal cell hyperplasia differs in reflux versus eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2006, 42:506–509.PubMedCrossRefGoogle Scholar
  30. 30.
    Ravelli AM, Villanacci V, Ruzzenenti N et al.: Dilated intercellular spaces: a major morphological feature of esophagitis. J Pediatr Gastroenterol Nutr 2006, 42:510–515.PubMedCrossRefGoogle Scholar
  31. 31.
    Fox VL, Nurko S, Furuta GT: Eosinophilic esophagitis: It’s not just kid’s stuff. Gatrointest Endosc 2002, 56:260–270. An excellent review of endoscopic findings in EE patients.CrossRefGoogle Scholar
  32. 32.
    Straumann A, Spichtin HP, Grize L, et al.: Natural history of primary eosinophilic desophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology 2003, 125:1660–1669. Currently the only paper on the natural history of EE.PubMedCrossRefGoogle Scholar
  33. 33.
    Orenstein SR, Shalaby TM, Di Lorenzo C, et al.: The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children. Am J Gastroenterol 2000, 95:1422–1430.PubMedCrossRefGoogle Scholar
  34. 34.
    Guajardo JR, Plotnick LM, Fende JM, et al.: Eosinophilassociated gastrointestinal disorders: a world-wide-web based registry. J Pedatr 2002, 141:576–81.CrossRefGoogle Scholar
  35. 35.
    Blanchard C, Wang N, Stringer KF, et al.: Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 2006, 116:536–547. A publication demonstrating the role of eotaxin-3 in EE versus chronic esophagitis using gene array profiling, genetic polymorphism studies, and CCR-3 deficient mice.PubMedCrossRefGoogle Scholar
  36. 36.
    Kelly KJ, Lazenby AJ, Rowe PC, et al.: Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 1995, 109:1503–1512.PubMedCrossRefGoogle Scholar
  37. 37.
    Spergel JM, Beausoleil JL, Mascarenhas M, et al.: The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol 2002, 109:363–368. The first study to describe the use of patch tests to identify food allergens implicated in EE.PubMedCrossRefGoogle Scholar
  38. 38.
    Teitelbaum JE, Fox VL, Twarog FJ, et al.: Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology 2002, 122:1216–1225.PubMedCrossRefGoogle Scholar
  39. 39.
    Simon D, Marti H, Heer P, et al.: Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway disease. J Allergy Clin Immunol 2005, 115:1090–1092. A letter to the editor describing EE in the context of other IgE mediated diseases.PubMedCrossRefGoogle Scholar
  40. 40.
    Fogg MJ, Ruchelli E, Spergel JM: Pollen and eosinophilic esophagitis. J Allergy Clin Immunol 2003, 112:796–797.PubMedCrossRefGoogle Scholar
  41. 41.
    Onbasi K, Sin AZ, Doganavsargil B, et al.: Eosinophil infiltration of the oesophageal mucosa in patients with pollen allergy during the season. Clin Exp Allergy 2005, 35:1423–1431. An interesting report of esophageal eosinophilia in pollen allergic patients.PubMedCrossRefGoogle Scholar
  42. 42.
    Straumann A, Bauer M, Fischer B, et al.: Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic Inflammatory response. J Allergy Clin Immunol 2001, 108:954–961. A paper demonstrating that EE is associated with a Th2 cytokine profile.PubMedCrossRefGoogle Scholar
  43. 43.
    Gupta SK, Fitzgerald JF, Kondratyuk T, et al.: Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 2006, 42:22–26. A paper demonstrating that EE is associated with a Th2 cytokine profile.PubMedCrossRefGoogle Scholar
  44. 44.
    Gupta SK, Peters-Golden M, Fitzgerald JF, et al.: Cysteinyl leukotriene levels in esophageal mucosal biopsies of children with eosinophilic Inflammation: are they all the same? Am J Gastroenterol 2006, 101:1125–1128.PubMedCrossRefGoogle Scholar
  45. 45.
    Akei HS, Mishra A, Blanchard C, et al.: Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice. Gastroenterology 2005, 129:985–994.PubMedCrossRefGoogle Scholar
  46. 46.
    Faubion WA Jr, Perrault J, Burgart LJ, et al.: Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr 1998, 27:90–93.PubMedCrossRefGoogle Scholar
  47. 47.
    Konikoff MR, Noel RJ, Blanchard C, et al.: A randomized double-blind placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology, In press.Google Scholar
  48. 48.
    Aceves SS, Dohil R, Newbury RO, et al.: Topical viscous budesonide suspension for treatment of eosinophilic esophagitis. J Allergy Clin Immunol 2005, 116:705–706.PubMedCrossRefGoogle Scholar
  49. 49.
    Liacouras CA, Spergel JM, Ruchelli E, et al.: Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 2005, 3:1198–1206. A comprehensive study detailing review of an experience in Philadelphia with dietary therapy in pediatric EE.PubMedCrossRefGoogle Scholar
  50. 50.
    Foroughi S, Mannon PJ, Bernardino LB, et al.: Pilot study of omalizumab in eosinophilic gastroenteritis. J Allergy Clin Immunol 2006, 117:S304.CrossRefGoogle Scholar
  51. 51.
    Garrett JK, Jameson SC, Thomson B, et al.: Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol 2004, 113:115–119.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2006

Authors and Affiliations

  1. 1.Division of Allergy, ImmunologyChildren’s Hospital of San DiegoSan DiegoUSA

Personalised recommendations